Anti-HER1 CAR-NK-92 cells also displayed increased apoptosis induction, CD107a expression and IFNγ secretion in co-culture with target cells, emphasizing the promising potential of CAR-NK cell therapy in HNSCC. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.